depression with semaglutide reduces effort discounting in depressed overweight patients The Potential of Ozempic in

In the quest to combat this epidemic, researchers have been exploring new drugs, including retatrutide, a novel triple agonist targeting the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon (GCG) receptors

Daily intraperitoneal administration for 11 days reduced body weight gain, decreased white adipose tissue mass by approximately 35%, and reduced adipocyte size, while food intake between treated and control groups did not differ significantly

High-fat foods: Fried foods, fatty cuts of meat, heavy cream sauces, excessive butter or oil

20 uM) compared with control treated hepatocytes